Cytokine polymorphisms influence treatment outcomes in SLE patients treated with antimalarial drugs

Arthritis Research & Therapy
Patricia LópezAna Suarez

Abstract

Antimalarial agents have been widely used as disease-modifying antirheumatic drugs in the treatment of systemic lupus erythematosus (SLE) and other rheumatological diseases, although their mechanism of action has not yet been fully defined. It is known, however, that effective response to treatment is variable among patients. Thus, the identification of genetic predictors of treatment response would provide valuable information for therapeutic intervention. The aim of the present study was to analyze the effect of antimalarial treatment on tumor necrosis factor (TNF)alpha serum levels and evaluate the possible influence of TNFalpha and IL-10 functional genetic polymorphisms on the response to antimalarial drugs. To this end, TNFalpha serum levels were quantified in 171 SLE patients and 215 healthy controls by ELISA techniques and polymorphisms at positions -1,082 and -308 of the IL-10 and TNFalpha gene promoters were determined by PCR amplification followed by hybridization with fluorescent-labeled allele-specific probes in 192 SLE patients and 343 matched controls. Data were related to clinical features and treatment at the time of sampling and during the course of the disease. Results showed a significantly higher amount of s...Continue Reading

References

Mar 1, 1988·Journal of Pharmaceutical Sciences·A C MacIntyre, D J Cutler
Jul 18, 1983·The American Journal of Medicine·G Salmeron, P E Lipsky
Nov 1, 1982·Arthritis and Rheumatism·E M TanR J Winchester
Feb 1, 1997·European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics·D M TurnerI V Hutchinson
Apr 1, 1997·Proceedings of the National Academy of Sciences of the United States of America·A G WilsonG W Duff
Jul 1, 1997·British Journal of Rheumatology·R I Rynes
Feb 18, 2003·The American Journal of the Medical Sciences·Andreas M Reimold
Oct 11, 2003·Autoimmunity Reviews·Arun G Suryaprasad, T Prindiville
Oct 7, 2004·Nucleic Acids Research·Hyouta HimenoAkira Muto
Apr 6, 2005·Lupus·J S SmolenM Aringer
Apr 13, 2005·Autoimmunity Reviews·Fabiola AtzeniFranco Capsoni
Apr 22, 2005·Annals of the Rheumatic Diseases·J C DavisW Tsuji
Sep 10, 2005·Best Practice & Research. Clinical Rheumatology·Jennifer H Anolik, Martin Aringer

❮ Previous
Next ❯

Citations

Mar 2, 2011·Toxicological Sciences : an Official Journal of the Society of Toxicology·Nilanjana BanerjeeAshok K Giri
Jul 20, 2007·Arthritis Research & Therapy·Arne HansenThomas Dörner
Nov 10, 2013·PloS One·Patricia LópezAna Suárez
Jul 14, 2010·Journal of Biomedicine & Biotechnology·Patricia LópezAna Suárez
Sep 29, 2015·Clinical Kidney Journal·Hans-Joachim AndersBrad Rovin
Sep 16, 2011·The Journal of Investigative Dermatology·Jan Dutz, Victoria P Werth
Apr 6, 2017·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·A CavalcantiN Lucena-Silva
Apr 10, 2013·Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences·Ali MandegaryElham Sharif
Feb 10, 2009·Cytometry. Part B, Clinical Cytometry·Susana Mellor-PitaJuan A Vargas
Jul 18, 2012·Nature Reviews. Rheumatology·Daniel J WallaceSwamy R Venuturupalli
Aug 10, 2011·Nature Reviews. Rheumatology·Lesley Davila, Prabha Ranganathan

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
genotyping
PCR

Software Mentioned

SPSS

Related Concepts

Related Feeds

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.